(Q42944119)

11 November 2017

title

Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo (English)

1 reference

11 November 2017

Yan Zhang

1

1 reference

11 November 2017

YanJun Cao

2

1 reference

11 November 2017

YingZhuan Zhan

3

1 reference

11 November 2017

Haijie Duan

4

1 reference

11 November 2017

LangChong He

5

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20691250

18 June 2024

publication date

4 August 2010

1 reference

full work available at URL

11 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S0367326X10002005?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

https://api.elsevier.com/content/article/PII:S0367326X10002005?httpAccept=text/plain

18 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

18 June 2024

1 reference

11 November 2017

volume

81

1 reference

11 November 2017

issue

8

1 reference

11 November 2017

page(s)

1188-1195

1 reference

Prevalence, awareness, treatment, and control of hypertension in china

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China

18 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns

18 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases.

18 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

The prevalence of hypertension and its association with other cardiovascular disease risk factors in a representative sample of the Lebanese population.

18 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa

18 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study

18 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Prevalence, awareness, treatment and control of hypertension in the Czech Republic. Results of two nationwide cross-sectional surveys in 1997/1998 and 2000/2001, Czech Post-MONICA Study

18 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia

18 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Hypertension and clustering of cardiovascular risk factors in a community in Southeast Brazil--The Bambuí Health and Ageing Study

18 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program.

18 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents

18 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

18 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents

18 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension

18 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis

18 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Treatment and post-treatment effects of alpha- versus beta-receptor blockers on left ventricular structure and function in essential hypertension

18 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Effects of antihypertensive drugs on cardiac hypertrophy

18 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males

18 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk

18 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Coating and fusing cell membranes onto a silica surface and their chromatographic characteristics

18 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Progress in cell membrane chromatography

18 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Chromatography studies on bio-affinity of nine ligands of alpha1-adrenoceptor to alpha1D subtypes overexpressed in cell membrane

18 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Evaluation of drug-muscarinic receptor affinities using cell membrane chromatography and radioligand binding assay in guinea pig jejunum membrane

18 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

The preparation of HEK293 alpha1A or HEK293 alpha1B cell membrane stationary phase and the chromatographic affinity study of ligands of alpha1 adrenoceptor

18 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Comparison of alpha1-adrenergic receptor cell-membrane stationary phases prepared from expressed cell line and from rabbit hepatocytes

18 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Screening, analysis and in vitro vasodilatation of effective components from Ligusticum Chuanxiong

18 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Establishment of the model of white blood cell membrane chromatography and screening of antagonizing TLR4 receptor component from Atractylodes macrocephala Koidz

18 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz

18 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro

18 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro

18 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Screening anti-inflammatory components from Chinese traditional medicines using a peritoneal macrophage/cell membrane chromatography-offline-GC/MS method

18 June 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Atractylenolide I and atractylenolide III inhibit Lipopolysaccharide-induced TNF-alpha and NO production in macrophages.

18 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

A vascular smooth muscle/cell membrane chromatography-offline-gas chromatography/mass spectrometry method for recognition, separation and identification of active components from traditional Chinese medicines

18 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Investigation of calcium antagonist-L-type calcium channel interactions by a vascular smooth muscle cell membrane chromatography method

18 June 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Natural products as sources of new drugs over the last 25 years

18 June 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Natural products as sources of new drugs over the period 1981-2002.

18 June 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway

18 June 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis

18 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation?

18 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin

18 June 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse

18 June 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats

18 June 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Inducible nitric oxide synthase inhibitor of the Chinese herb I. Saposhnikovia divaricata (Turcz.) Schischk

18 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.

18 June 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway

18 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy

18 June 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

18 June 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis

18 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.FITOTE.2010.07.023

18 June 2024

Identifiers

1 reference

11 November 2017

1 reference